Four Reasons ECMO Programs Stall
ECMO is specialized enough that the learning curve carries real clinical and financial consequences, and there is no shortcut to the institutional knowledge that takes years to accumulate.
ECMO is specialized enough that the learning curve carries real clinical and financial consequences, and there is no shortcut to the institutional knowledge that takes years to accumulate.
Shyld AI has raised $13.4 million to expand its AI-powered UV disinfection platform, which autonomously sanitizes hospital rooms. The startup’s technology aims to reduce the risk of hospital-acquired infection, as well as lessen hospitals’ reliance on labor-intensive cleaning workflows.
CMS imposed a six-month nationwide freeze on new Medicare enrollments for hospices and home health agencies as part of a broader crackdown on fraud in the sectors.
Sanford Health signed a deal to acquire North Memorial Health, which could be its long-sought entry into the Twin Cities market. The move is the latest in a series of expansion efforts for the South Dakota-based health system.
Beth Israel Lahey Health said modernizing its fax infrastructure during a major Epic EHR consolidation helped the health system slash fax failure rates from 34% to 4% and save $4 million. By adopting Retarus’ cloud-based platform, the health system simplified referrals and prescription processing, as well as reduced manual administrative work.
By embracing better tools and smarter approaches, agencies can reduce the strain on their teams and give their patients the most seamless, high-quality care possible.
Enterprise EHR boosts scalability, interoperability, and governance for large healthcare systems.
For the triage nurse, it comes down to understanding nuance and unique patient needs, whether that’s identifying an acute condition or just lending a listening ear.
A comment docket dominated by hospital lobby framing produces a rule that reflects that framing. A comment docket that includes documented employer cost analysis, physician ownership experience, and market structure argument produces a different rule.
Is $50 billion over five years enough to end the rural healthcare crisis or even offset the federal spending cuts? No – but it’s what states have to work with. And the pressure is on them to maximize the impact of their RHTP grants. Here’s how they can do it.
A new report from Gibbins Advisors showed that healthcare bankruptcy filings rose 33% in the first quarter of 2026, driven mostly by outpatient and senior care providers. At the same time, hospital M&A activity rebounded to its strongest first quarter since early 2020.
The most successful and high-performing health systems will approach TEAM not as a regulatory burden, but as a catalyst for transformation. They will use this moment to build the operating model, processes, workflows, and culture that position their health system for long-term success in value-based care.
Disagreements between providers and payers have been moving into the courtroom over the past few weeks. The California Hospital Association sued Anthem over one of its out-of-network policies, Broward Health sued Florida Blue over alleged underpayment, and Jefferson Health sued Aetna over a Medicare Advantage hospital stay rule.
A proposed merger between Atrium Health and WakeMed Health is facing an early delay, with county commissioners having postponed a key vote over transparency concerns. State officials are warning the deal could hurt competition and drive up healthcare costs in the Raleigh area.
EHRs not only document care but can also act as a financial engine to bridge the gap between patient care and prompt reimbursement. Here's how to bring the two sides together to alleviate tedious administrative burdens.
A Massachusetts regulator is warning that CVS and Mass General Brigham’s proposed MinuteClinic partnership could drive up healthcare spending by at least $40 million annually, largely through steering patients into a higher-priced system. Experts said the deal might improve convenience for some patients but is unlikely to meaningfully expand access — and could ultimately strengthen market power and push costs even higher.